i-Pharma 2022 will provide an opportunity for the participating companies to display their products & services to the gamut of visitors, globally from the pharma and healthcare industries. The 2-day expo will bring together eminent personalities from various sectors of pharma, non-pharma, and healthcare industries. i-Pharma 2022 is aimed at bringing together all the pharma professionals under one roof, the pharmaceutical exhibition focused on knowledge, technology, and business development. i-Pharma 2022 is one stop juncture to all those who are planning to expand their business through various channels of franchise and distribution.
i-Pharma 2022 will showcase the latest trends and technologies in pharmaceuticals, drugs, and formulations; direct access to highly targeted senior pharma executives, buyers, procurement managers, contract manufacturers, hospital administration and many more
For more details of floor plan & price quotation contact email@example.com
The global pharmaceuticals market is experiencing persistent growth due to the worldwide increase in life expectancy, as well as the growing incidence of infectious and chronic diseases. The constantly increasing demand for innovative drugs has thus triggered a remarkable rise in R&D investments in the pharmaceuticals industry. The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and over-the-counter drugs being manufactured. Clinical trials are managed to ensure that products being developed are tested to learn how well they work on individuals affected by the diseases or conditions they are designed to treat. The industry’s main contribution is engaging in technological advancements through innovative research to meet the complex healthcare demands of populations.
At a compound annual growth rate (CAGR) of 1.8 percent, the worldwide pharmaceutical market is predicted to rise from $1228.45 billion in 2020 to $1250.24 billion in 2021. At an annual growth rate of 8%, the market is estimated to reach $1700.97 billion in 2025. The increase is primarily due to companies reorganising their operations and recovering from the impact of COVID-19, which had previously resulted in restrictive containment measures such as social distancing, remote working, and the closure of commercial activities, all of which created operational challenges.
Increased drug approvals, rising prevalence of chronic ailments, a growing geriatric population, high investment in research and development, and rising per capita healthcare expenditure will drive the global pharmaceutical manufacturing industry to $673.6 billion by 2027, up 12.5 percent annually from 2020 to 2027. The global COVID-19 Clinical Trials market was worth USD 4,195.28 million in 2020, is predicted to increase to USD 4,721.78 million in 2021, and to USD 9,818.55 million by 2027, with a CAGR of 12.91 percent.
You boost your firm visibility among hundreds of visiting global industry professionals at i-Pharma Congress in 2022, which is designed as a must-attend pharmaceutical event. You will have direct contact with your target audience as well as the opportunity to speak with company decision makers who require your products and services one-on-one.
Download Exhibitor-Sponsor Catalog from below
Get involved with us along with other related industry experts and stay ahead of the curve. No matter how large or small your marketing budget, you'll benefit from significant sources of visibility from these opportunities.